Washington University in St. Louis (WU)
I am dedicated to advancing precision medicine in hematologic malignancies, with a particular focus on diffuse large B-cell lymphoma (DLBCL). My research centers on integrating whole genome sequencing (WGS) into clinical practice to streamline molecular profiling, enhance risk stratification, and guide personalized therapeutic interventions. I design and implement investigator-initiated clinical trials that incorporate translational research, bridging bench discoveries with clinical applications. Additionally, I emphasize innovative trial methodologies—including adaptive designs and correlative studies—to address critical gaps in lymphoma management. I am also involved in evaluating and implementing novel drugs and vaccines to further refine treatment paradigms. Through multidisciplinary collaborations, I strive to transform genomic insights into actionable clinical strategies that improve patient outcomes in lymphoma care.